» Articles » PMID: 10618063

Polymorphism in the Pertussis Toxin Promoter Region Affecting the DNA-based Diagnosis of Bordetella Infection

Overview
Specialty Microbiology
Date 2000 Jan 5
PMID 10618063
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The pertussis toxin (PT) promoter region is a frequently used target for DNA-based diagnosis of pertussis and parapertussis infections. The reported polymorphism in this region has also allowed discrimination of species in mixtures with several Bordetella species by their specific PCR amplicon restriction patterns. In the present study, we investigated the degree of polymorphism in order to confirm the reliability of the assay. Five different sequence types of the amplified 239- or 249-bp region were found among the 33 Bordetella pertussis, B. parapertussis, and B. bronchiseptica American Type Culture Collection reference strains and patient isolates analyzed. According to the sequences that were obtained and according to the PT promoter sequences already available in the databases, restriction enzyme analysis with TaqI, BglI, and HaeII, which gave four different patterns, can be performed to reliably identify B. pertussis, B. parapertussis, and B. bronchiseptica.

Citing Articles

A pangenome approach-based loop-mediated isothermal amplification assay for the specific and early detection of Bordetella pertussis.

Juscamayta-Lopez E, Valdivia F, Soto M, Nurena B, Horna H Sci Rep. 2023; 13(1):4356.

PMID: 36928221 PMC: 10018623. DOI: 10.1038/s41598-023-29773-9.


Loop-Mediated Isothermal Amplification Coupled With Nanoparticle-Based Lateral Biosensor for Rapid, Sensitive, and Specific Detection of .

Sun C, Xiao F, Fu J, Huang X, Jia N, Xu Z Front Bioeng Biotechnol. 2022; 9:797957.

PMID: 35211469 PMC: 8861531. DOI: 10.3389/fbioe.2021.797957.


Establishment and application of a multiple cross displacement amplification combined with nanoparticles-based biosensor method for the detection of Bordetella pertussis.

Li S, Liu C, Liu Y, Ma Q, Wang Y, Wang Y BMC Microbiol. 2020; 20(1):263.

PMID: 32831029 PMC: 7444059. DOI: 10.1186/s12866-020-01945-x.


Laboratory Diagnosis of Pertussis.

van der Zee A, Schellekens J, Mooi F Clin Microbiol Rev. 2015; 28(4):1005-26.

PMID: 26354823 PMC: 4575397. DOI: 10.1128/CMR.00031-15.


A Case of Bordetella brochiseptica at a Military Medical Facility in Hawai'i: Phenotypic and Molecular Testing of an Uncommon Human Pathogen.

Washington M, Agee W, Kajiura L, Hawley-Molloy J, Staege C, Barnhill J Hawaii J Med Public Health. 2015; 74(7):230-3.

PMID: 26225268 PMC: 4507362.


References
1.
Reizenstein E, Lindberg L, Mollby R, Hallander H . Validation of nested Bordetella PCR in pertussis vaccine trial. J Clin Microbiol. 1996; 34(4):810-5. PMC: 228897. DOI: 10.1128/jcm.34.4.810-815.1996. View

2.
Erlandsson A, Backman A, Tornqvist E, Olcen P, Olsen P . PCR assay or culture for diagnosis of Bordetella pertussis in the routine diagnostic laboratory?. J Infect. 1998; 35(3):221-4. DOI: 10.1016/s0163-4453(97)92738-9. View

3.
Hoppe J . Update of epidemiology, diagnosis, and treatment of pertussis. Eur J Clin Microbiol Infect Dis. 1996; 15(3):189-93. DOI: 10.1007/BF01591352. View

4.
Grimprel E, Begue P, Anjak I, Betsou F, Guiso N . Comparison of polymerase chain reaction, culture, and western immunoblot serology for diagnosis of Bordetella pertussis infection. J Clin Microbiol. 1993; 31(10):2745-50. PMC: 266003. DOI: 10.1128/jcm.31.10.2745-2750.1993. View

5.
Reizenstein E, Johansson B, Mardin L, Abens J, Mollby R, Hallander H . Diagnostic evaluation of polymerase chain reaction discriminative for Bordetella pertussis, B. parapertussis, and B. bronchiseptica. Diagn Microbiol Infect Dis. 1993; 17(3):185-91. DOI: 10.1016/0732-8893(93)90094-n. View